RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
First Claim
1. An isolated double-stranded short interfering nucleic acid (siNA) molecule that inhibits the expression of cadherin-associated protein, beta 1 (CTNNB1), wherein(a) the siNA comprises a sense strand and an antisense strand;
- (b) each strand is independently 15 to 30 nucleotides in length; and
(c) at least one strand comprises at least a 15 nucleotide sequence of any one of the nucleotide sequences selected from the group consisting of SEQ ID NO;
1-6374.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of CTNNB1 gene expression and/or activity, and/or modulate a beta-catenin gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against CTNNB1 gene expression.
-
Citations
39 Claims
-
1. An isolated double-stranded short interfering nucleic acid (siNA) molecule that inhibits the expression of cadherin-associated protein, beta 1 (CTNNB1), wherein
(a) the siNA comprises a sense strand and an antisense strand; -
(b) each strand is independently 15 to 30 nucleotides in length; and (c) at least one strand comprises at least a 15 nucleotide sequence of any one of the nucleotide sequences selected from the group consisting of SEQ ID NO;
1-6374. - View Dependent Claims (6, 7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 30, 38)
-
-
2-5. -5. (canceled)
-
12. (canceled)
-
18-29. -29. (canceled)
-
31-37. -37. (canceled)
-
39. The method according to claim 39, wherein the condition is cancer.
Specification